Biomarker
Showing 26 - 39 of 39
miRNA Biomarkers in Multiple Sclerosis
Completed
- Multiple Sclerosis
- +3 more
- miRNA
- (no location specified)
Feb 23, 2021
Liver Tumor Malignant Primary, Cholangiocarcinoma, Combinational Immunotherapy Trial in Beijing (Lenvatinib plus Pembrolizumab)
Recruiting
- Liver Neoplasm Malignant Primary
- +3 more
- Lenvatinib plus Pembrolizumab
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 22, 2020
BAL of ICU Patients With Lung Infiltrates
Unknown status
- INvasive Aspergillosis
- +4 more
-
Mannheim, GermanyMannheim University Hospital
Apr 17, 2020
Serum BDNF Role as a Biomarker for Stroke Rehabilitation
Completed
- Stroke
- +3 more
- Conventional inpatient rehabilitation
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 16, 2020
GVHD,Acute, Biomarker Trial in Beijing (aGVHD biomarker)
Recruiting
- GVHD,Acute
- Biomarker
- aGVHD biomarker
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Feb 24, 2020
(TIMP-2)x(IGFPB7) to Predict Acute Kidney Injury in Aortic
Completed
- Renal Failure
- +4 more
- does not apply
-
Bern, SwitzerlandInselspital
Sep 23, 2019
Cognitive Function, Well-Being, Physical Function Trial in Lisbon (Singing Group Intervention Program, Alternative Social and
Unknown status
- Cognitive Function
- +22 more
- Singing Group Intervention Program
- Alternative Social and Leisure Activities
-
Lisbon, PortugalUniversidade Autónoma de Lisboa
Jun 13, 2019
Mild Cognitive Impairment, Biomarker, Diagnosis Trial in Shanghai (Huperzine A, Placebo)
Not yet recruiting
- Mild Cognitive Impairment
- +3 more
- Huperzine A
- Placebo
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Apr 13, 2019
Myocarditis, Heart Failure, Endomyocardial Biopsy Trial in Warsaw (ECG holter monitoring)
Unknown status
- Myocarditis
- +6 more
- ECG holter monitoring
-
Warsaw, Poland1st Chair and Department of Cardiology, Medical University of Wa
Jan 10, 2019
Stroke, Motor Activity, Biomarker Trial in Paris (standard stroke rehabilitation)
Unknown status
- Stroke
- +2 more
- standard stroke rehabilitation
-
Paris, FranceICM
Nov 9, 2018
Osteosarcoma, Feasibility, Treatment Response Trial in Goyang-si (Poor responder group adjuvant chemo, Good responder group
Unknown status
- Osteosarcoma
- +3 more
- Poor responder group adjuvant chemotherapy
- Good responder group adjuvant chemotherapy
-
Goyang-si, Gyeonggi, Korea, Republic ofNational Cancer Center
Jan 5, 2018
Gastric Cancer, Apatinib, Biomarker Trial in Bengbu (Apatinib mesylate tablets)
Unknown status
- Gastric Cancer
- +2 more
- Apatinib mesylate tablets
-
Bengbu, Anhui, ChinaDepartment of Medical Oncology, First Affiliated Hospital of Ben
Sep 7, 2017
Biomarker Trial in Glasgow (VB-201 or Placebo)
Completed
- Biomarker
- VB-201 or Placebo
-
Glasgow, Scotland, United KingdomVBL Investigative Site
Nov 15, 2011